Mobistix Junior Instant (Paracetamol)

Paracetamol works by inhibiting cyclooxygenase enzymes in the central nervous system, which reduces the production of prostaglandins. Lower prostaglandin levels diminish pain signals and reset the hypothalamic temperature set‑point, providing analgesic and antipyretic effects.

The appropriate dose of Mobistix Junior Instant is determined by a qualified prescriber based on the child’s age, weight, and clinical condition. Healthcare professionals follow established pediatric dosing guidelines to ensure safety and effectiveness.

Paracetamol is generally considered the preferred analgesic/antipyretic during pregnancy and lactation, but the safety of Mobistix Junior Instant for these populations should be confirmed by a healthcare provider. The prescriber will weigh potential benefits against any risks.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mobistix Junior Instant delivers paracetamol, which unlike NSAIDs does not have significant anti‑inflammatory activity or gastrointestinal irritation. It is often preferred for children when a mild analgesic/antipyretic is needed without the bleeding risk associated with ibuprofen or aspirin.

Store Mobistix Junior Instant at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight and extreme heat to maintain stability and potency.

Mobistix Junior Instant is taken orally. The liquid formulation is measured using a calibrated dosing device (such as a syringe or cup) and given directly into the mouth. Administration should follow the prescriber’s instructions regarding timing and frequency.

The most serious risks include severe liver injury, especially with overdose or in patients with pre‑existing liver disease, and rare but life‑threatening skin reactions such as Stevens‑Johnson syndrome. Prompt medical attention is required if signs of liver dysfunction or severe rash appear.

Children with known hypersensitivity to paracetamol or any excipients in the formulation should avoid it. It is also contraindicated in patients with severe hepatic impairment or those who have experienced serious adverse reactions to paracetamol previously.